ARANESP
NDC 55513-002, darbepoetin alfa, solution, from Amgen, Inc.
- Product NDC
- 55513-002
- Status
- Listed
- Labeler
- Amgen, Inc
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA103951
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55513-002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DARBEPOETIN ALFA25 ug/mL
Pharmacologic classes
Erythropoiesis-stimulating Agent [EPC]; Erythropoietin [CS]; Increased Erythroid Cell Production [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55513-002-04 | 55513000204 | 4 VIAL, SINGLE-DOSE in 1 PACKAGE (55513-002-04) / 1 mL in 1 VIAL, SINGLE-DOSE (55513-002-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/0fd36cb9-c4f6-4167-93c9-8530865db3f9Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=55513-002
Use it
Look up 55513-002 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55513-002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55513-002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.